Clinical Trial Update: An Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism [Phase 2]

View source ↗

Summary

A Phase 2 cohort study to evaluate the safety and efficacy of XH-02 for hypoparathyroidism, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• XH-02

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Hypoparathyroidism | Phase 2 | Status: RECRUITING